単純ヘルペスウイルス治療薬の世界市場規模、シェア、産業動向分析レポート薬剤タイプ別、種類別、流通チャネル別、地域別展望と予測、2022年～2028年

単純ヘルペスウイルス治療薬市場規模は、2028年には21億米ドルに達すると予測され、予測期間中にCAGR 3.0%の市場成長率で上昇すると予想されています。

口唇ヘルペスは通常、無症状ですが、時に口腔内やその周辺に痛みを伴う水疱や潰瘍ができることがあります。また、口内炎ができる前に、感染者は口の周りがヒリヒリしたり、熱くなったり、かゆくなったりすることを頻繁に感じる。これらの再発の頻度は、個人差があります。

性器ヘルペスの中程度の症状や無症状は、気づかないことが多いようです。性器ヘルペスの症状が初めて現れた時には、1つ以上の肛門または性器の潰瘍または水疱が存在します。発熱、体の痛み、リンパ節の腫脹は、新鮮な感染のさらなる兆候です。症状は初回から再発することがありますが、かなり重症化することがあります。HSV-1による性器ヘルペスは、ほとんどの場合、再発することはほとんどありません。HSV-2の再発は典型的です。しかし、再発しても初回ほど長くは続かず、時間の経過とともに軽快していきます。

COVID-19の影響度分析

単純ヘルペスウイルス感染症は、パンデミックを通じて緩やかに発症していたが、抗ウイルス薬の必要性や早期診断・治療の必要性から、パンデミックによって注目されたウイルス感染症です。その結果、単純ヘルペスウイルスの治療需要は、パンデミック時にやや増加しました。また、遠隔医療が普及したことで、パンデミックの影響で交通手段が制限され、社会的に孤立していたヘルペス感染症の治療がより簡便に行えるようになりました。その結果、単純ヘルペスウイルス治療薬の市場は恩恵を受けた。したがって、市場はパンデミックの影響を受けたマイナス成長から立ち直り、今後数年間は上昇を続けるでしょう。

市場の成長要因

単純ヘルペスウイルス感染症の増加

患者さんが症状を抑え、感染リスクを下げる方法を模索する中、性の健康に対する価値観が高まるにつれて、HSV治療に対する需要が高まってきています。また、発展途上国における医療費の増加により、HSV治療のようなヘルスケアサービスがより利用しやすくなってきています。このため、ヘルスケアへのアクセスが改善され、HSV治療薬の需要が高まっています。したがって、HSV感染症の有病率の上昇は、治療と投薬の需要を促進し、ひいては単純ヘルペスウイルス治療市場の成長を後押ししています。

HSV検査と治療薬の開発が進む

多くの啓発活動により、病気に関する知識や治療法の普及が進み、診断や治療が受けやすくなっています。ヘルペス感染が広く知られるようになると、より多くの人が治療に名乗りを上げるようになり、先進国では効率的な治療法への需要が高まっています。さらに、低開発国や新興国において一般的なヘルペス治療薬が入手しやすくなっていることから、市場参入企業はこれらの地域でより高度な治療薬を提供するよう促しています。したがって、これらすべての要因が、今後数年間の市場開拓を後押ししています。

市場抑制要因

最も使用されているヘルペス治療薬の優先的な副作用について

アシクロビルの抑制的な治療薬の投与により、アシクロビル耐性HSV株の確立が問題となっています。これは，第2選択薬であるシドホビルやフォスカルネットがアシクロビルよりも比較的毒性が強いため，問題視されています。文献的には、アシクロビルの長期抑制治療を受けていた赤ちゃんにアシクロビル耐性HSVが出現したとの報告があります。また、別の研究では、喉頭にアシクロビル耐性HSVを有する生後10日の乳児が記載されています。したがって、ヘルペス治療薬の長期使用による副作用は、今後数年間の市場の成長を妨げる可能性があります。

タイプ別展望

単純ヘルペスウイルス治療市場は、タイプに基づいて、単純ヘルペスウイルス-1感染と単純ヘルペスウイルス-2感染に分類されます。単純ヘルペスウイルス-2感染症セグメントは、2021年の単純ヘルペスウイルス治療市場においてかなりの成長率を調達しました。HSV-2感染症例の増加は、HSV-1感染の既往がある人がHSV-2に再感染するリスクの上昇に起因していると考えられます。そのため、母親から胎児に感染する可能性があるため、適切かつ迅速な治療が重要です。また、企業による新規治療法の創出も進んでいます。したがって、この疾患に関する研究の増加や有病率の上昇により、このセグメントは予測期間を通じて成長すると考えられます。

薬剤タイプの展望

薬剤の種類に基づき、単純ヘルペスウイルス治療市場はアシクロビル、バラシクロビル、ファムシクロビルに分けられます。単純ヘルペスウイルス治療薬市場では、2021年にバラシクロビルセグメントが最大の収益シェアを獲得しました。HSV感染症が広く知られるようになり、患者が早期治療を目指すなど積極的に行動するようになったことが、このセグメントが拡大する理由です。また、バラシクロビルは安全性に優れているため、使用頻度が高くなっています。また、バラシクロビルは安価で入手しやすく、ヘルペスウイルスが体内で複製されるのを防ぎ、発症時の症状を改善する効果があることから、需要が高まっています。

流通チャネルの展望

流通チャネルに基づいて、単純ヘルペスウイルス治療市場は、病院薬局、ドラッグストア＆小売薬局、およびオンラインプロバイダーに区分されます。2021年の単純ヘルペスウイルス治療市場では、ドラッグストア・小売薬局のセグメントが最大の収益シェアを示しました。抗ウイルス薬を含むHSV感染症のためのさまざまな薬剤や治療法を提供するドラッグストアや小売薬局は、このセグメントの成長に寄与していると考えられます。これらの薬局の利用が増加しているのは、HSV治療用の市販薬が簡単に入手できることに起因しています。

地域の展望

地域別に見ると、単純ヘルペスウイルス治療市場は、北米、欧州、アジア太平洋、LAMEAで分析されています。北米セグメントは、2021年に単純ヘルペスウイルス治療市場で最も高い収益シェアを調達しました。多数の有力企業や同地域の単純ヘルペスウイルス治療薬製造技術の向上が、同地域の主な市場促進要因となっています。さらに、強力なヘルスケアシステム、高い購買力、単純ヘルペスウイルス感染症の治療におけるアシクロビル使用の増加が、市場の拡大を促進すると予想されます。

目次

第1章 市場範囲と調査手法

• 市場の定義
• 目的
• 市場範囲
• セグメンテーション
  • 世界の単純ヘルペスウイルス治療市場：薬剤の種類別
  • 世界の単純ヘルペスウイルス治療市場：タイプ別
  • 世界の単純ヘルペスウイルス治療市場：流通チャネル別
  • 世界の単純ヘルペスウイルス治療市場：地域別
• 調査手法

第2章 市場概要

• イントロダクション
  • 概要
    • 市場構成とシナリオ
• 市場に影響を与える主な要因
  • 市場促進要因
  • 市場抑制要因

第3章 世界の単純ヘルペスウイルス治療市場：薬の種類別

• 世界のバラシクロビル市場：地域別
• 世界のアシクロビル市場：地域別
• 世界のファムシクロビル市場：地域別

第4章 世界の単純ヘルペスウイルス治療市場：タイプ別

• 世界の単純ヘルペスウイルス-1感染市場：地域別
• 世界の単純ヘルペスウイルス2感染市場：地域別

第5章 世界の単純ヘルペスウイルス治療市場：流通チャネル別

• 世界のドラッグストアおよび小売薬局市場：地域別
• 世界の病院薬局市場：地域別
• 世界オンライン薬局市場：地域別

第6章 世界の単純ヘルペスウイルス治療市場：地域別

• 北米
  • 北米の市場：国別
    • 米国
    • カナダ
    • メキシコ
    • その他北米地域
• 欧州
  • 欧州の市場：国別
    • ドイツ
    • 英国
    • フランス
    • ロシア
    • スペイン
    • イタリア
    • その他欧州地域
• アジア太平洋
  • アジア太平洋の市場：国別
    • 中国
    • 日本
    • インド
    • 韓国
    • シンガポール
    • マレーシア
    • その他アジア太平洋地域
• ラテンアメリカ・中東・アフリカ
  • ラテンアメリカ・中東・アフリカの市場：国別
    • ブラジル
    • アルゼンチン
    • アラブ首長国連邦
    • サウジアラビア
    • 南アフリカ
    • ナイジェリア
    • その他ラテンアメリカ・中東・アフリカ地域

第7章 企業プロファイル

• Abbott Laboratories
• Pfizer, Inc
• Amneal Pharmaceuticals, Inc
• GlaxoSmithKline PLC（GSK）
• Teva Pharmaceutical Industries Ltd
• Glenmark Pharmaceuticals Limited
• Fresenius SE & Co KGaA
• Novartis AG
• Viatris, Inc
• Emcure Pharmaceuticals Limited

LIST OF TABLES

• TABLE 1 Global Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 2 Global Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 3 Global Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 4 Global Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 5 Global Valacyclovir Market by Region, 2018 - 2021, USD Million
• TABLE 6 Global Valacyclovir Market by Region, 2022 - 2028, USD Million
• TABLE 7 Global Acyclovir Market by Region, 2018 - 2021, USD Million
• TABLE 8 Global Acyclovir Market by Region, 2022 - 2028, USD Million
• TABLE 9 Global Famciclovir Market by Region, 2018 - 2021, USD Million
• TABLE 10 Global Famciclovir Market by Region, 2022 - 2028, USD Million
• TABLE 11 Global Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 12 Global Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 13 Global Herpes simplex virus-1 Infection Market by Region, 2018 - 2021, USD Million
• TABLE 14 Global Herpes simplex virus-1 Infection Market by Region, 2022 - 2028, USD Million
• TABLE 15 Global Herpes simplex virus-2 Infection Market by Region, 2018 - 2021, USD Million
• TABLE 16 Global Herpes simplex virus-2 Infection Market by Region, 2022 - 2028, USD Million
• TABLE 17 Global Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 18 Global Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 19 Global Drug Store & Retail Pharmacies Market by Region, 2018 - 2021, USD Million
• TABLE 20 Global Drug Store & Retail Pharmacies Market by Region, 2022 - 2028, USD Million
• TABLE 21 Global Hospital Pharmacies Market by Region, 2018 - 2021, USD Million
• TABLE 22 Global Hospital Pharmacies Market by Region, 2022 - 2028, USD Million
• TABLE 23 Global Online Pharmacies Market by Region, 2018 - 2021, USD Million
• TABLE 24 Global Online Pharmacies Market by Region, 2022 - 2028, USD Million
• TABLE 25 Global Herpes Simplex Virus Treatment Market by Region, 2018 - 2021, USD Million
• TABLE 26 Global Herpes Simplex Virus Treatment Market by Region, 2022 - 2028, USD Million
• TABLE 27 North America Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 28 North America Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 29 North America Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 30 North America Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 31 North America Valacyclovir Market by Country, 2018 - 2021, USD Million
• TABLE 32 North America Valacyclovir Market by Country, 2022 - 2028, USD Million
• TABLE 33 North America Acyclovir Market by Country, 2018 - 2021, USD Million
• TABLE 34 North America Acyclovir Market by Country, 2022 - 2028, USD Million
• TABLE 35 North America Famciclovir Market by Country, 2018 - 2021, USD Million
• TABLE 36 North America Famciclovir Market by Country, 2022 - 2028, USD Million
• TABLE 37 North America Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 38 North America Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 39 North America Herpes simplex virus-1 Infection Market by Country, 2018 - 2021, USD Million
• TABLE 40 North America Herpes simplex virus-1 Infection Market by Country, 2022 - 2028, USD Million
• TABLE 41 North America Herpes simplex virus-2 Infection Market by Country, 2018 - 2021, USD Million
• TABLE 42 North America Herpes simplex virus-2 Infection Market by Country, 2022 - 2028, USD Million
• TABLE 43 North America Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 44 North America Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 45 North America Drug Store & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
• TABLE 46 North America Drug Store & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
• TABLE 47 North America Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
• TABLE 48 North America Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
• TABLE 49 North America Online Pharmacies Market by Country, 2018 - 2021, USD Million
• TABLE 50 North America Online Pharmacies Market by Country, 2022 - 2028, USD Million
• TABLE 51 North America Herpes Simplex Virus Treatment Market by Country, 2018 - 2021, USD Million
• TABLE 52 North America Herpes Simplex Virus Treatment Market by Country, 2022 - 2028, USD Million
• TABLE 53 US Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 54 US Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 55 US Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 56 US Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 57 US Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 58 US Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 59 US Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 60 US Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 61 Canada Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 62 Canada Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 63 Canada Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 64 Canada Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 65 Canada Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 66 Canada Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 67 Canada Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 68 Canada Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 69 Mexico Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 70 Mexico Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 71 Mexico Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 72 Mexico Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 73 Mexico Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 74 Mexico Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 75 Mexico Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 76 Mexico Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 77 Rest of North America Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 78 Rest of North America Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 79 Rest of North America Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 80 Rest of North America Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 81 Rest of North America Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 82 Rest of North America Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 83 Rest of North America Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 84 Rest of North America Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 85 Europe Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 86 Europe Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 87 Europe Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 88 Europe Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 89 Europe Valacyclovir Market by Country, 2018 - 2021, USD Million
• TABLE 90 Europe Valacyclovir Market by Country, 2022 - 2028, USD Million
• TABLE 91 Europe Acyclovir Market by Country, 2018 - 2021, USD Million
• TABLE 92 Europe Acyclovir Market by Country, 2022 - 2028, USD Million
• TABLE 93 Europe Famciclovir Market by Country, 2018 - 2021, USD Million
• TABLE 94 Europe Famciclovir Market by Country, 2022 - 2028, USD Million
• TABLE 95 Europe Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 96 Europe Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 97 Europe Herpes simplex virus-1 Infection Market by Country, 2018 - 2021, USD Million
• TABLE 98 Europe Herpes simplex virus-1 Infection Market by Country, 2022 - 2028, USD Million
• TABLE 99 Europe Herpes simplex virus-2 Infection Market by Country, 2018 - 2021, USD Million
• TABLE 100 Europe Herpes simplex virus-2 Infection Market by Country, 2022 - 2028, USD Million
• TABLE 101 Europe Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 102 Europe Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 103 Europe Drug Store & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
• TABLE 104 Europe Drug Store & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
• TABLE 105 Europe Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
• TABLE 106 Europe Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
• TABLE 107 Europe Online Pharmacies Market by Country, 2018 - 2021, USD Million
• TABLE 108 Europe Online Pharmacies Market by Country, 2022 - 2028, USD Million
• TABLE 109 Europe Herpes Simplex Virus Treatment Market by Country, 2018 - 2021, USD Million
• TABLE 110 Europe Herpes Simplex Virus Treatment Market by Country, 2022 - 2028, USD Million
• TABLE 111 Germany Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 112 Germany Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 113 Germany Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 114 Germany Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 115 Germany Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 116 Germany Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 117 Germany Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 118 Germany Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 119 UK Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 120 UK Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 121 UK Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 122 UK Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 123 UK Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 124 UK Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 125 UK Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 126 UK Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 127 France Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 128 France Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 129 France Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 130 France Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 131 France Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 132 France Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 133 France Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 134 France Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 135 Russia Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 136 Russia Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 137 Russia Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 138 Russia Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 139 Russia Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 140 Russia Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 141 Russia Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 142 Russia Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 143 Spain Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 144 Spain Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 145 Spain Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 146 Spain Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 147 Spain Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 148 Spain Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 149 Spain Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 150 Spain Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 151 Italy Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 152 Italy Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 153 Italy Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 154 Italy Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 155 Italy Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 156 Italy Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 157 Italy Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 158 Italy Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 159 Rest of Europe Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 160 Rest of Europe Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 161 Rest of Europe Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 162 Rest of Europe Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 163 Rest of Europe Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 164 Rest of Europe Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 165 Rest of Europe Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 166 Rest of Europe Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 167 Asia Pacific Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 168 Asia Pacific Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 169 Asia Pacific Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 170 Asia Pacific Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 171 Asia Pacific Valacyclovir Market by Country, 2018 - 2021, USD Million
• TABLE 172 Asia Pacific Valacyclovir Market by Country, 2022 - 2028, USD Million
• TABLE 173 Asia Pacific Acyclovir Market by Country, 2018 - 2021, USD Million
• TABLE 174 Asia Pacific Acyclovir Market by Country, 2022 - 2028, USD Million
• TABLE 175 Asia Pacific Famciclovir Market by Country, 2018 - 2021, USD Million
• TABLE 176 Asia Pacific Famciclovir Market by Country, 2022 - 2028, USD Million
• TABLE 177 Asia Pacific Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 178 Asia Pacific Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 179 Asia Pacific Herpes simplex virus-1 Infection Market by Country, 2018 - 2021, USD Million
• TABLE 180 Asia Pacific Herpes simplex virus-1 Infection Market by Country, 2022 - 2028, USD Million
• TABLE 181 Asia Pacific Herpes simplex virus-2 Infection Market by Country, 2018 - 2021, USD Million
• TABLE 182 Asia Pacific Herpes simplex virus-2 Infection Market by Country, 2022 - 2028, USD Million
• TABLE 183 Asia Pacific Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 184 Asia Pacific Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 185 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
• TABLE 186 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
• TABLE 187 Asia Pacific Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
• TABLE 188 Asia Pacific Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
• TABLE 189 Asia Pacific Online Pharmacies Market by Country, 2018 - 2021, USD Million
• TABLE 190 Asia Pacific Online Pharmacies Market by Country, 2022 - 2028, USD Million
• TABLE 191 Asia Pacific Herpes Simplex Virus Treatment Market by Country, 2018 - 2021, USD Million
• TABLE 192 Asia Pacific Herpes Simplex Virus Treatment Market by Country, 2022 - 2028, USD Million
• TABLE 193 China Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 194 China Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 195 China Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 196 China Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 197 China Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 198 China Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 199 China Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 200 China Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 201 Japan Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 202 Japan Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 203 Japan Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 204 Japan Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 205 Japan Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 206 Japan Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 207 Japan Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 208 Japan Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 209 India Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 210 India Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 211 India Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 212 India Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 213 India Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 214 India Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 215 India Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 216 India Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 217 South Korea Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 218 South Korea Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 219 South Korea Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 220 South Korea Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 221 South Korea Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 222 South Korea Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 223 South Korea Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 224 South Korea Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 225 Singapore Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 226 Singapore Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 227 Singapore Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 228 Singapore Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 229 Singapore Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 230 Singapore Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 231 Singapore Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 232 Singapore Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 233 Malaysia Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 234 Malaysia Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 235 Malaysia Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 236 Malaysia Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 237 Malaysia Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 238 Malaysia Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 239 Malaysia Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 240 Malaysia Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 241 Rest of Asia Pacific Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 242 Rest of Asia Pacific Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 243 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 244 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 245 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 246 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 247 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 248 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 249 LAMEA Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 250 LAMEA Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 251 LAMEA Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 252 LAMEA Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 253 LAMEA Valacyclovir Market by Country, 2018 - 2021, USD Million
• TABLE 254 LAMEA Valacyclovir Market by Country, 2022 - 2028, USD Million
• TABLE 255 LAMEA Acyclovir Market by Country, 2018 - 2021, USD Million
• TABLE 256 LAMEA Acyclovir Market by Country, 2022 - 2028, USD Million
• TABLE 257 LAMEA Famciclovir Market by Country, 2018 - 2021, USD Million
• TABLE 258 LAMEA Famciclovir Market by Country, 2022 - 2028, USD Million
• TABLE 259 LAMEA Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 260 LAMEA Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 261 LAMEA Herpes simplex virus-1 Infection Market by Country, 2018 - 2021, USD Million
• TABLE 262 LAMEA Herpes simplex virus-1 Infection Market by Country, 2022 - 2028, USD Million
• TABLE 263 LAMEA Herpes simplex virus-2 Infection Market by Country, 2018 - 2021, USD Million
• TABLE 264 LAMEA Herpes simplex virus-2 Infection Market by Country, 2022 - 2028, USD Million
• TABLE 265 LAMEA Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 266 LAMEA Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 267 LAMEA Drug Store & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
• TABLE 268 LAMEA Drug Store & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
• TABLE 269 LAMEA Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
• TABLE 270 LAMEA Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
• TABLE 271 LAMEA Online Pharmacies Market by Country, 2018 - 2021, USD Million
• TABLE 272 LAMEA Online Pharmacies Market by Country, 2022 - 2028, USD Million
• TABLE 273 LAMEA Herpes Simplex Virus Treatment Market by Country, 2018 - 2021, USD Million
• TABLE 274 LAMEA Herpes Simplex Virus Treatment Market by Country, 2022 - 2028, USD Million

• TABLE 275 Brazil Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 276 Brazil Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 277 Brazil Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 278 Brazil Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 279 Brazil Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 280 Brazil Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 281 Brazil Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 282 Brazil Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 283 Argentina Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 284 Argentina Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 285 Argentina Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 286 Argentina Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 287 Argentina Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 288 Argentina Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 289 Argentina Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 290 Argentina Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 291 UAE Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 292 UAE Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 293 UAE Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 294 UAE Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 295 UAE Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 296 UAE Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 297 UAE Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 298 UAE Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 299 Saudi Arabia Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 300 Saudi Arabia Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 301 Saudi Arabia Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 302 Saudi Arabia Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 303 Saudi Arabia Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 304 Saudi Arabia Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 305 Saudi Arabia Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 306 Saudi Arabia Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 307 South Africa Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 308 South Africa Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 309 South Africa Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 310 South Africa Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 311 South Africa Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 312 South Africa Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 313 South Africa Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 314 South Africa Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 315 Nigeria Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 316 Nigeria Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 317 Nigeria Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 318 Nigeria Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 319 Nigeria Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 320 Nigeria Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 321 Nigeria Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 322 Nigeria Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 323 Rest of LAMEA Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
• TABLE 324 Rest of LAMEA Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
• TABLE 325 Rest of LAMEA Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
• TABLE 326 Rest of LAMEA Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
• TABLE 327 Rest of LAMEA Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
• TABLE 328 Rest of LAMEA Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
• TABLE 329 Rest of LAMEA Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 330 Rest of LAMEA Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 331 Key Information - Abbott Laboratories
• TABLE 332 Key Information - Pfizer, Inc.
• TABLE 333 Key Information - Amneal Pharmaceuticals, INc.
• TABLE 334 Key Information - GlaxoSmithKline PLC
• TABLE 335 Key Information - Teva Pharmaceuticals Industries Ltd.
• TABLE 336 Key Information - Glenmark Pharmaceuticals Limited
• TABLE 337 key information - Fresenius SE & Co. KGaA
• TABLE 338 Key Information - Novartis AG
• TABLE 339 key information - Viatris, Inc.
• TABLE 340 Key Information - Emcure Pharmaceuticals Limited

List of Figures

• FIG 1 Methodology for the research
• FIG 2 Global Herpes Simplex Virus Treatment Market share by Drug Type, 2021
• FIG 3 Global Herpes Simplex Virus Treatment Market share by Drug Type, 2028
• FIG 4 Global Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2028, USD Million
• FIG 5 Global Herpes Simplex Virus Treatment Market share by Type, 2021
• FIG 6 Global Herpes Simplex Virus Treatment Market share by Type, 2028
• FIG 7 Global Herpes Simplex Virus Treatment Market by Type, 2018 - 2028, USD Million
• FIG 8 Global Herpes Simplex Virus Treatment Market share by Distribution Channel, 2021
• FIG 9 Global Herpes Simplex Virus Treatment Market share by Distribution Channel, 2028
• FIG 10 Global Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2028, USD Million
• FIG 11 Global Herpes Simplex Virus Treatment Market share by Region, 2021
• FIG 12 Global Herpes Simplex Virus Treatment Market share by Region, 2028
• FIG 13 Global Herpes Simplex Virus Treatment Market by Region, 2018 - 2028, USD Million
• FIG 14 Swot analysis: Abbott laboratories

The Global Herpes Simplex Virus Treatment Market size is expected to reach $2.1 billion by 2028, rising at a market growth of 3.0% CAGR during the forecast period.

Herpes simplex virus is a prevalent sexually transmitted infection (STI) that affects people. Herpes simplex virus type 1 (HSV-1) as well as herpes simplex virus type 2 (HSV-2) are the two types. Cold sores and oral herpes are frequently linked to HSV-1. Therefore, oral intercourse can potentially result in genital herpes. HSV-2 typically causes genital herpes and can also transmit oral herpes during oral intercourse. Both forms of herpes are extremely contagious and can be spread by touching an infected person's saliva or genital secretions.

Herpes severity and frequency are decreased by antiviral drugs like acyclovir, which prevent virus reproduction. The other medications, such as famciclovir and valacyclovir, suppress viral DNA synthesis, stopping the virus from reproducing and generating symptoms. There are many different formulations of these drugs, including topical ointments and oral pills. Since there is presently no effective treatment for HSV infection, the current therapies mainly aim to manage symptoms and lessen the frequency and intensity of outbreaks. However, because of the substantial medical need, this has created in the market for HSV therapies, new medicines are being developed, and there is a rising need for efficient treatments.

Although oral herpes is typically asymptomatic, it can occasionally cause painful blisters or ulcers in or around the mouth. In addition, before sores develop, infected people frequently feel a tingling, burning, or itchy feeling around their mouth. The frequency of these recurrences varies from individual to individual.

Many times, the moderate or asymptomatic symptoms of genital herpes can go unnoticed. One or more anal or genital ulcers or blisters are present when symptoms of genital herpes first appear. Fever, bodily aches, and enlarged lymph nodes are additional signs of a fresh infection. Symptoms can return after the first episode, though they can be quite severe. HSV-1-induced genital herpes seldom recurs in most cases. Recurrent symptoms of HSV-2 are typical. Recurrences, nevertheless, typically don't last as long as the initial episode and become milder over time.

COVID-19 Impact Analysis

Herpes simplex virus infections, which exhibited a moderate development throughout the pandemic, were among the viral infections brought to light by the COVID-19 pandemic due to the necessity of antiviral medications and the requirement for early diagnosis and treatment. Consequently, the demand for treating the herpes simplex virus increased somewhat during the pandemic. Additionally, telemedicine became more widely used, making it simpler for patients to get treatment for herpes infections due to the pandemic's restrictions on transportation and social isolation. The market for herpes simplex virus treatment benefited as a result. Therefore, the market will rise from the pandemic-influenced negative growth and continue to rise in the coming years.

Market Growth Factors

Increasing prevalence of herpes simplex virus infections

As patients look for ways to control their symptoms and lower the risk of transmission, there is a rising demand for HSV therapies as awareness of the value of sexual health grows. Also, healthcare services, like HSV treatment, are now more available due to increases in healthcare spending in developing nations. This has improved healthcare access and raised the demand for HSV treatments. Therefore the rising prevalence of HSV infection is propelling the demand for treatment and medication, which in turn is boosting the growth of the herpes simplex virus treatment market.

Rising development of HSV testing and medications

Numerous awareness programs have aided in increasing the knowledge about the disease as well as the availability of treatment methods, which in turn has facilitated the uptake of diagnosis and treatment. As herpes infections become more widely known, more individuals are coming forward and getting therapy, which increases the demand for efficient treatments in industrialized nations. Moreover, the increasing availability of common herpes medications in underdeveloped and developing nations has prompted market participants to provide more advanced medication in these regions. Hence, all these factors are propelling the development of the market in the coming years.

Market Restraining Factors

Prevalent side effects of most used herpes medications

The administration of suppressive acyclovir treatments has caused the establishment of acyclovir-resistant HSV strains. This is a problem because the second-line anti-herpes medications, cidofovir and foscarnet, are comparatively more toxic than acyclovir. One report in the literature describes the emergence of acyclovir-resistant HSV in a baby receiving long-term suppressive acyclovir treatment. In addition, a 10-day-old baby with acyclovir-resistant HSV in the larynx is described in another study. Therefore, the side effects of long-term usage of herpes medication may hamper the market's growth in the coming years.

Type Outlook

Based on type, the herpes simplex virus treatment market is categorized into herpes simplex virus-1 infection and herpes simplex virus-2 infection. The herpes simplex virus-2 infection segment procured a considerable growth rate in the herpes simplex virus treatment market in 2021. The rise in cases of HSV-2 infection can be ascribed to an elevated risk of HSV-2 reinfection in individuals with a previous HSV-1 infection. Therefore, appropriate and prompt therapy is crucial because the infection can pass from the mother to the fetus. In addition, businesses are creating novel treatments. Therefore, the segment will grow throughout the forecast period due to increased research into the disease and its rising prevalence.

Drug Type Outlook

On the basis of drug type, the herpes simplex virus treatment market is divided into acyclovir, valacyclovir, and famciclovir. The valacyclovir segment acquired the largest revenue share in the herpes simplex virus treatment market in 2021. HSV infections are becoming more widely known, and patients are acting more proactively by pursuing early treatment, which is why the segment is expanding. Additionally, valacyclovir is used more frequently because of its superior safety rating. The affordability, accessibility, and efficacy of valacyclovir in preventing the herpes virus from replicating in the body and thereby assisting in managing an outbreak's symptoms also increase its demand.

Distribution Channel Outlook

Based on distribution channel, the herpes simplex virus treatment market is segmented into hospital pharmacies, drug store & retail pharmacies, and online providers. The drug store and retail pharmacies segment witnessed the maximum revenue share in the herpes simplex virus treatment market in 2021. Drug shops and retail pharmacies offering a range of drugs and treatments for HSV infections, including antiviral drugs, are credited with the segment's growth. The growing usage of these pharmacies is owed to the simple availability of over-the-counter medications for treating HSV.

Regional Outlook

On the basis of region, the herpes simplex virus treatment market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the herpes simplex virus treatment market in 2021. Numerous influential companies and improvements in the region's herpes simplex virus treatment manufacturing technology are the main market drivers in the region. Additionally, a strong healthcare system, high purchasing power, as well as rising acyclovir use for treating herpes simplex virus infection are anticipated to fuel market expansion.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Pfizer, Inc., Amneal Pharmaceuticals, Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., Glenmark Pharmaceuticals Limited, Fresenius SE & Co. KGaA, Novartis AG, Viatris, Inc., and Emcure Pharmaceuticals Limited.

Scope of the Study

Market Segments covered in the Report:

By Drug Type

• Valacyclovir
• Acyclovir
• Famciclovir

By Type

• Herpes simplex virus-1 Infection
• Herpes simplex virus-2 Infection

By Distribution Channel

• Drug Store & Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Abbott Laboratories
• Pfizer, Inc.
• Amneal Pharmaceuticals, Inc.
• GlaxoSmithKline PLC
• Teva Pharmaceuticals Industries Ltd.
• Glenmark Pharmaceuticals Limited
• Fresenius SE & Co. KGaA
• Novartis AG
• Viatris, Inc.
• Emcure Pharmaceuticals Limited

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Herpes Simplex Virus Treatment Market, by Drug Type
  • 1.4.2 Global Herpes Simplex Virus Treatment Market, by Type
  • 1.4.3 Global Herpes Simplex Virus Treatment Market, by Distribution Channel
  • 1.4.4 Global Herpes Simplex Virus Treatment Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market Overview

• 2.1 Introduction
  • 2.1.1 Overview
    • 2.1.1.1 Market Composition & Scenario
• 2.2 Key Factors Impacting the Market
  • 2.2.1 Market Drivers
  • 2.2.2 Market Restraints

Chapter 3. Global Herpes Simplex Virus Treatment Market by Drug Type

• 3.1 Global Valacyclovir Market by Region
• 3.2 Global Acyclovir Market by Region
• 3.3 Global Famciclovir Market by Region

Chapter 4. Global Herpes Simplex Virus Treatment Market by Type

• 4.1 Global Herpes simplex virus-1 Infection Market by Region
• 4.2 Global Herpes simplex virus-2 Infection Market by Region

Chapter 5. Global Herpes Simplex Virus Treatment Market by Distribution Channel

• 5.1 Global Drug Store & Retail Pharmacies Market by Region
• 5.2 Global Hospital Pharmacies Market by Region
• 5.3 Global Online Pharmacies Market by Region

Chapter 6. Global Herpes Simplex Virus Treatment Market by Region

• 6.1 North America Herpes Simplex Virus Treatment Market
  • 6.1.1 North America Herpes Simplex Virus Treatment Market by Drug Type
    • 6.1.1.1 North America Valacyclovir Market by Country
    • 6.1.1.2 North America Acyclovir Market by Country
    • 6.1.1.3 North America Famciclovir Market by Country
  • 6.1.2 North America Herpes Simplex Virus Treatment Market by Type
    • 6.1.2.1 North America Herpes simplex virus-1 Infection Market by Country
    • 6.1.2.2 North America Herpes simplex virus-2 Infection Market by Country
  • 6.1.3 North America Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.1.3.1 North America Drug Store & Retail Pharmacies Market by Country
    • 6.1.3.2 North America Hospital Pharmacies Market by Country
    • 6.1.3.3 North America Online Pharmacies Market by Country
  • 6.1.4 North America Herpes Simplex Virus Treatment Market by Country
    • 6.1.4.1 US Herpes Simplex Virus Treatment Market
      • 6.1.4.1.1 US Herpes Simplex Virus Treatment Market by Drug Type
      • 6.1.4.1.2 US Herpes Simplex Virus Treatment Market by Type
      • 6.1.4.1.3 US Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.1.4.2 Canada Herpes Simplex Virus Treatment Market
      • 6.1.4.2.1 Canada Herpes Simplex Virus Treatment Market by Drug Type
      • 6.1.4.2.2 Canada Herpes Simplex Virus Treatment Market by Type
      • 6.1.4.2.3 Canada Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.1.4.3 Mexico Herpes Simplex Virus Treatment Market
      • 6.1.4.3.1 Mexico Herpes Simplex Virus Treatment Market by Drug Type
      • 6.1.4.3.2 Mexico Herpes Simplex Virus Treatment Market by Type
      • 6.1.4.3.3 Mexico Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.1.4.4 Rest of North America Herpes Simplex Virus Treatment Market
      • 6.1.4.4.1 Rest of North America Herpes Simplex Virus Treatment Market by Drug Type
      • 6.1.4.4.2 Rest of North America Herpes Simplex Virus Treatment Market by Type
      • 6.1.4.4.3 Rest of North America Herpes Simplex Virus Treatment Market by Distribution Channel
• 6.2 Europe Herpes Simplex Virus Treatment Market
  • 6.2.1 Europe Herpes Simplex Virus Treatment Market by Drug Type
    • 6.2.1.1 Europe Valacyclovir Market by Country
    • 6.2.1.2 Europe Acyclovir Market by Country
    • 6.2.1.3 Europe Famciclovir Market by Country
  • 6.2.2 Europe Herpes Simplex Virus Treatment Market by Type
    • 6.2.2.1 Europe Herpes simplex virus-1 Infection Market by Country
    • 6.2.2.2 Europe Herpes simplex virus-2 Infection Market by Country
  • 6.2.3 Europe Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.2.3.1 Europe Drug Store & Retail Pharmacies Market by Country
    • 6.2.3.2 Europe Hospital Pharmacies Market by Country
    • 6.2.3.3 Europe Online Pharmacies Market by Country
  • 6.2.4 Europe Herpes Simplex Virus Treatment Market by Country
    • 6.2.4.1 Germany Herpes Simplex Virus Treatment Market
      • 6.2.4.1.1 Germany Herpes Simplex Virus Treatment Market by Drug Type
      • 6.2.4.1.2 Germany Herpes Simplex Virus Treatment Market by Type
      • 6.2.4.1.3 Germany Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.2.4.2 UK Herpes Simplex Virus Treatment Market
      • 6.2.4.2.1 UK Herpes Simplex Virus Treatment Market by Drug Type
      • 6.2.4.2.2 UK Herpes Simplex Virus Treatment Market by Type
      • 6.2.4.2.3 UK Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.2.4.3 France Herpes Simplex Virus Treatment Market
      • 6.2.4.3.1 France Herpes Simplex Virus Treatment Market by Drug Type
      • 6.2.4.3.2 France Herpes Simplex Virus Treatment Market by Type
      • 6.2.4.3.3 France Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.2.4.4 Russia Herpes Simplex Virus Treatment Market
      • 6.2.4.4.1 Russia Herpes Simplex Virus Treatment Market by Drug Type
      • 6.2.4.4.2 Russia Herpes Simplex Virus Treatment Market by Type
      • 6.2.4.4.3 Russia Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.2.4.5 Spain Herpes Simplex Virus Treatment Market
      • 6.2.4.5.1 Spain Herpes Simplex Virus Treatment Market by Drug Type
      • 6.2.4.5.2 Spain Herpes Simplex Virus Treatment Market by Type
      • 6.2.4.5.3 Spain Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.2.4.6 Italy Herpes Simplex Virus Treatment Market
      • 6.2.4.6.1 Italy Herpes Simplex Virus Treatment Market by Drug Type
      • 6.2.4.6.2 Italy Herpes Simplex Virus Treatment Market by Type
      • 6.2.4.6.3 Italy Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.2.4.7 Rest of Europe Herpes Simplex Virus Treatment Market
      • 6.2.4.7.1 Rest of Europe Herpes Simplex Virus Treatment Market by Drug Type
      • 6.2.4.7.2 Rest of Europe Herpes Simplex Virus Treatment Market by Type
      • 6.2.4.7.3 Rest of Europe Herpes Simplex Virus Treatment Market by Distribution Channel
• 6.3 Asia Pacific Herpes Simplex Virus Treatment Market
  • 6.3.1 Asia Pacific Herpes Simplex Virus Treatment Market by Drug Type
    • 6.3.1.1 Asia Pacific Valacyclovir Market by Country
    • 6.3.1.2 Asia Pacific Acyclovir Market by Country
    • 6.3.1.3 Asia Pacific Famciclovir Market by Country
  • 6.3.2 Asia Pacific Herpes Simplex Virus Treatment Market by Type
    • 6.3.2.1 Asia Pacific Herpes simplex virus-1 Infection Market by Country
    • 6.3.2.2 Asia Pacific Herpes simplex virus-2 Infection Market by Country
  • 6.3.3 Asia Pacific Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.3.3.1 Asia Pacific Drug Store & Retail Pharmacies Market by Country
    • 6.3.3.2 Asia Pacific Hospital Pharmacies Market by Country
    • 6.3.3.3 Asia Pacific Online Pharmacies Market by Country
  • 6.3.4 Asia Pacific Herpes Simplex Virus Treatment Market by Country
    • 6.3.4.1 China Herpes Simplex Virus Treatment Market
      • 6.3.4.1.1 China Herpes Simplex Virus Treatment Market by Drug Type
      • 6.3.4.1.2 China Herpes Simplex Virus Treatment Market by Type
      • 6.3.4.1.3 China Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.3.4.2 Japan Herpes Simplex Virus Treatment Market
      • 6.3.4.2.1 Japan Herpes Simplex Virus Treatment Market by Drug Type
      • 6.3.4.2.2 Japan Herpes Simplex Virus Treatment Market by Type
      • 6.3.4.2.3 Japan Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.3.4.3 India Herpes Simplex Virus Treatment Market
      • 6.3.4.3.1 India Herpes Simplex Virus Treatment Market by Drug Type
      • 6.3.4.3.2 India Herpes Simplex Virus Treatment Market by Type
      • 6.3.4.3.3 India Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.3.4.4 South Korea Herpes Simplex Virus Treatment Market
      • 6.3.4.4.1 South Korea Herpes Simplex Virus Treatment Market by Drug Type
      • 6.3.4.4.2 South Korea Herpes Simplex Virus Treatment Market by Type
      • 6.3.4.4.3 South Korea Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.3.4.5 Singapore Herpes Simplex Virus Treatment Market
      • 6.3.4.5.1 Singapore Herpes Simplex Virus Treatment Market by Drug Type
      • 6.3.4.5.2 Singapore Herpes Simplex Virus Treatment Market by Type
      • 6.3.4.5.3 Singapore Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.3.4.6 Malaysia Herpes Simplex Virus Treatment Market
      • 6.3.4.6.1 Malaysia Herpes Simplex Virus Treatment Market by Drug Type
      • 6.3.4.6.2 Malaysia Herpes Simplex Virus Treatment Market by Type
      • 6.3.4.6.3 Malaysia Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.3.4.7 Rest of Asia Pacific Herpes Simplex Virus Treatment Market
      • 6.3.4.7.1 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Drug Type
      • 6.3.4.7.2 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Type
      • 6.3.4.7.3 Rest of Asia Pacific Herpes Simplex Virus Treatment Market by Distribution Channel
• 6.4 LAMEA Herpes Simplex Virus Treatment Market
  • 6.4.1 LAMEA Herpes Simplex Virus Treatment Market by Drug Type
    • 6.4.1.1 LAMEA Valacyclovir Market by Country
    • 6.4.1.2 LAMEA Acyclovir Market by Country
    • 6.4.1.3 LAMEA Famciclovir Market by Country
  • 6.4.2 LAMEA Herpes Simplex Virus Treatment Market by Type
    • 6.4.2.1 LAMEA Herpes simplex virus-1 Infection Market by Country
    • 6.4.2.2 LAMEA Herpes simplex virus-2 Infection Market by Country
  • 6.4.3 LAMEA Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.4.3.1 LAMEA Drug Store & Retail Pharmacies Market by Country
    • 6.4.3.2 LAMEA Hospital Pharmacies Market by Country
    • 6.4.3.3 LAMEA Online Pharmacies Market by Country
  • 6.4.4 LAMEA Herpes Simplex Virus Treatment Market by Country
    • 6.4.4.1 Brazil Herpes Simplex Virus Treatment Market
      • 6.4.4.1.1 Brazil Herpes Simplex Virus Treatment Market by Drug Type
      • 6.4.4.1.2 Brazil Herpes Simplex Virus Treatment Market by Type
      • 6.4.4.1.3 Brazil Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.4.4.2 Argentina Herpes Simplex Virus Treatment Market
      • 6.4.4.2.1 Argentina Herpes Simplex Virus Treatment Market by Drug Type
      • 6.4.4.2.2 Argentina Herpes Simplex Virus Treatment Market by Type
      • 6.4.4.2.3 Argentina Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.4.4.3 UAE Herpes Simplex Virus Treatment Market
      • 6.4.4.3.1 UAE Herpes Simplex Virus Treatment Market by Drug Type
      • 6.4.4.3.2 UAE Herpes Simplex Virus Treatment Market by Type
      • 6.4.4.3.3 UAE Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.4.4.4 Saudi Arabia Herpes Simplex Virus Treatment Market
      • 6.4.4.4.1 Saudi Arabia Herpes Simplex Virus Treatment Market by Drug Type
      • 6.4.4.4.2 Saudi Arabia Herpes Simplex Virus Treatment Market by Type
      • 6.4.4.4.3 Saudi Arabia Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.4.4.5 South Africa Herpes Simplex Virus Treatment Market
      • 6.4.4.5.1 South Africa Herpes Simplex Virus Treatment Market by Drug Type
      • 6.4.4.5.2 South Africa Herpes Simplex Virus Treatment Market by Type
      • 6.4.4.5.3 South Africa Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.4.4.6 Nigeria Herpes Simplex Virus Treatment Market
      • 6.4.4.6.1 Nigeria Herpes Simplex Virus Treatment Market by Drug Type
      • 6.4.4.6.2 Nigeria Herpes Simplex Virus Treatment Market by Type
      • 6.4.4.6.3 Nigeria Herpes Simplex Virus Treatment Market by Distribution Channel
    • 6.4.4.7 Rest of LAMEA Herpes Simplex Virus Treatment Market
      • 6.4.4.7.1 Rest of LAMEA Herpes Simplex Virus Treatment Market by Drug Type
      • 6.4.4.7.2 Rest of LAMEA Herpes Simplex Virus Treatment Market by Type
      • 6.4.4.7.3 Rest of LAMEA Herpes Simplex Virus Treatment Market by Distribution Channel

Chapter 7. Company Profiles

• 7.1 Abbott Laboratories
  • 7.1.1 Company Overview
  • 7.1.2 Financial Analysis
  • 7.1.3 Segmental and Regional Analysis
  • 7.1.4 Research & Development Expense
  • 7.1.5 SWOT Analysis
• 7.2 Pfizer, Inc.
  • 7.2.1 Company Overview
  • 7.2.2 Financial Analysis
  • 7.2.3 Regional & Segmental Analysis
  • 7.2.4 Research & Development Expense
  • 7.2.5 Recent strategies and developments:
    • 7.2.5.1 Partnerships, Collaborations, and Agreements:
• 7.3 Amneal Pharmaceuticals, Inc.
  • 7.3.1 Company Overview
  • 7.3.2 Financial Analysis
  • 7.3.3 Segmental Analysis
  • 7.3.4 Research & Development Expenses
  • 7.3.5 Recent strategies and developments:
    • 7.3.5.1 Approvals and Trials:
• 7.4 GlaxoSmithKline PLC (GSK)
  • 7.4.1 Company Overview
  • 7.4.2 Financial Analysis
  • 7.4.3 Segmental and Regional Analysis
  • 7.4.4 Research & Development Expense
  • 7.4.5 Recent strategies and developments:
    • 7.4.5.1 Approvals and Trials:
• 7.5 Teva Pharmaceutical Industries Ltd.
  • 7.5.1 Company Overview
  • 7.5.2 Financial Analysis
  • 7.5.3 Regional Analysis
  • 7.5.4 Research & Development Expenses
• 7.6 Glenmark Pharmaceuticals Limited
  • 7.6.1 Company Overview
  • 7.6.2 Financial Analysis
  • 7.6.3 Regional Analysis
  • 7.6.4 Research & Development Expenses
• 7.7 Fresenius SE & Co. KGaA
  • 7.7.1 Company Overview
  • 7.7.2 Financial Analysis
  • 7.7.3 Segmental and Regional Analysis
  • 7.7.4 Research & Development Expenses
• 7.8 Novartis AG
  • 7.8.1 Company Overview
  • 7.8.2 Financial Analysis
  • 7.8.3 Segmental and Regional Analysis
  • 7.8.4 Research & Development Expense
• 7.9 Viatris, Inc.
  • 7.9.1 Company Overview
  • 7.9.2 Financial Analysis
  • 7.9.3 Segmental Analysis
  • 7.9.4 Research & Development Expense
• 7.10. Emcure Pharmaceuticals Limited
  • 7.10.1 Company Overview